1
|
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.
|
Nat Immunol
|
2003
|
38.57
|
2
|
Regulatory T cell lineage specification by the forkhead transcription factor foxp3.
|
Immunity
|
2005
|
23.00
|
3
|
Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice.
|
Nat Immunol
|
2006
|
14.33
|
4
|
TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.
|
Nature
|
2008
|
14.26
|
5
|
A function for interleukin 2 in Foxp3-expressing regulatory T cells.
|
Nat Immunol
|
2005
|
11.48
|
6
|
Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces.
|
Immunity
|
2008
|
9.82
|
7
|
Regulatory T cells: mechanisms of differentiation and function.
|
Annu Rev Immunol
|
2012
|
9.75
|
8
|
Foxp3-dependent programme of regulatory T-cell differentiation.
|
Nature
|
2007
|
9.48
|
9
|
Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells.
|
Nature
|
2007
|
7.04
|
10
|
Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors.
|
Immunity
|
2004
|
6.89
|
11
|
Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate.
|
Nature
|
2010
|
6.87
|
12
|
TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells.
|
J Exp Med
|
2005
|
6.87
|
13
|
Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3.
|
Nat Immunol
|
2007
|
6.80
|
14
|
A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3.
|
Nat Immunol
|
2005
|
6.77
|
15
|
Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses.
|
Nature
|
2009
|
6.65
|
16
|
In vivo analysis of dendritic cell development and homeostasis.
|
Science
|
2009
|
6.42
|
17
|
An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires.
|
Nat Immunol
|
2006
|
6.16
|
18
|
CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner.
|
Science
|
2009
|
6.14
|
19
|
Foxp3 in control of the regulatory T cell lineage.
|
Nat Immunol
|
2007
|
5.94
|
20
|
Th17 and regulatory T cells in mediating and restraining inflammation.
|
Cell
|
2010
|
5.89
|
21
|
Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity.
|
Immunity
|
2003
|
5.52
|
22
|
Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development.
|
Proc Natl Acad Sci U S A
|
2006
|
5.50
|
23
|
Coordination of early protective immunity to viral infection by regulatory T cells.
|
Science
|
2008
|
5.33
|
24
|
Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10.
|
Nat Immunol
|
2007
|
5.14
|
25
|
Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein.
|
Immunity
|
2009
|
5.10
|
26
|
Stability of the regulatory T cell lineage in vivo.
|
Science
|
2010
|
4.89
|
27
|
Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses.
|
Cell
|
2010
|
4.57
|
28
|
Extrathymically generated regulatory T cells control mucosal TH2 inflammation.
|
Nature
|
2012
|
4.33
|
29
|
Developmental regulation of Foxp3 expression during ontogeny.
|
J Exp Med
|
2005
|
4.32
|
30
|
Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor.
|
Immunity
|
2006
|
4.06
|
31
|
Dicer-dependent microRNA pathway safeguards regulatory T cell function.
|
J Exp Med
|
2008
|
3.70
|
32
|
The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease.
|
J Exp Med
|
2008
|
3.45
|
33
|
Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation.
|
Immunity
|
2011
|
3.40
|
34
|
Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner.
|
Immunity
|
2011
|
3.38
|
35
|
Intraclonal competition limits the fate determination of regulatory T cells in the thymus.
|
Nat Immunol
|
2009
|
3.38
|
36
|
Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict.
|
Cell
|
2012
|
3.24
|
37
|
Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis.
|
J Exp Med
|
2007
|
3.21
|
38
|
Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease.
|
J Exp Med
|
2007
|
3.17
|
39
|
TGFbeta signalling in control of T-cell-mediated self-reactivity.
|
Nat Rev Immunol
|
2007
|
3.02
|
40
|
Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells.
|
J Exp Med
|
2012
|
2.97
|
41
|
Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification.
|
Cell
|
2012
|
2.79
|
42
|
Novel Foxo1-dependent transcriptional programs control T(reg) cell function.
|
Nature
|
2012
|
2.77
|
43
|
Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-β pathway.
|
J Exp Med
|
2010
|
2.54
|
44
|
Transcriptome-wide miR-155 binding map reveals widespread noncanonical microRNA targeting.
|
Mol Cell
|
2012
|
2.54
|
45
|
IPS-1 is essential for the control of West Nile virus infection and immunity.
|
PLoS Pathog
|
2010
|
2.39
|
46
|
Lysosomal cysteine proteases regulate antigen presentation.
|
Nat Rev Immunol
|
2003
|
2.25
|
47
|
Differentiation of regulatory Foxp3+ T cells in the thymic cortex.
|
Proc Natl Acad Sci U S A
|
2008
|
2.24
|
48
|
Tregs control the development of symptomatic West Nile virus infection in humans and mice.
|
J Clin Invest
|
2009
|
2.18
|
49
|
The plasticity and stability of regulatory T cells.
|
Nat Rev Immunol
|
2013
|
2.15
|
50
|
Transcription factor Foxp3 and its protein partners form a complex regulatory network.
|
Nat Immunol
|
2012
|
2.10
|
51
|
Runx-CBFbeta complexes control expression of the transcription factor Foxp3 in regulatory T cells.
|
Nat Immunol
|
2009
|
2.02
|
52
|
Importance of group X-secreted phospholipase A2 in allergen-induced airway inflammation and remodeling in a mouse asthma model.
|
J Exp Med
|
2007
|
1.96
|
53
|
Thymic development and peripheral homeostasis of regulatory T cells.
|
Curr Opin Immunol
|
2007
|
1.88
|
54
|
Effects of the administration of high-dose interleukin-2 on immunoregulatory cell subsets in patients with advanced melanoma and renal cell cancer.
|
Clin Cancer Res
|
2007
|
1.84
|
55
|
The lysosomal cysteine proteases in MHC class II antigen presentation.
|
Immunol Rev
|
2005
|
1.78
|
56
|
Autocrine transforming growth factor-β1 promotes in vivo Th17 cell differentiation.
|
Immunity
|
2011
|
1.72
|
57
|
IL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells.
|
J Exp Med
|
2013
|
1.68
|
58
|
Mechanisms of donor-specific transfusion tolerance: preemptive induction of clonal T-cell exhaustion via indirect presentation.
|
Blood
|
2003
|
1.57
|
59
|
Cutting edge: TCR stimulation is sufficient for induction of Foxp3 expression in the absence of DNA methyltransferase 1.
|
J Immunol
|
2009
|
1.55
|
60
|
IL-2-dependent adaptive control of NK cell homeostasis.
|
J Exp Med
|
2013
|
1.50
|
61
|
An N-terminal mutation of the Foxp3 transcription factor alleviates arthritis but exacerbates diabetes.
|
Immunity
|
2012
|
1.50
|
62
|
Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy.
|
J Exp Med
|
2013
|
1.47
|
63
|
Mouse TCRalphabeta+CD8alphaalpha intraepithelial lymphocytes express genes that down-regulate their antigen reactivity and suppress immune responses.
|
J Immunol
|
2007
|
1.47
|
64
|
Control of inflammation by integration of environmental cues by regulatory T cells.
|
J Clin Invest
|
2013
|
1.43
|
65
|
A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation.
|
J Immunol
|
2002
|
1.35
|
66
|
Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).
|
Blood
|
2004
|
1.34
|
67
|
A critical role for regulatory T cell-mediated control of inflammation in the absence of commensal microbiota.
|
J Exp Med
|
2010
|
1.32
|
68
|
Thymocyte expression of cathepsin L is essential for NKT cell development.
|
Nat Immunol
|
2002
|
1.27
|
69
|
Lack of Foxp3 function and expression in the thymic epithelium.
|
J Exp Med
|
2007
|
1.22
|
70
|
Analysis of the underlying cellular mechanisms of anti-CD154-induced graft tolerance: the interplay of clonal anergy and immune regulation.
|
J Immunol
|
2005
|
1.22
|
71
|
Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo.
|
J Immunol
|
2005
|
1.15
|
72
|
The nuclear orphan receptor Nr4a2 induces Foxp3 and regulates differentiation of CD4+ T cells.
|
Nat Commun
|
2011
|
1.15
|
73
|
Crystal structure of MHC class II I-Ab in complex with a human CLIP peptide: prediction of an I-Ab peptide-binding motif.
|
J Mol Biol
|
2003
|
1.14
|
74
|
Stage-specific regulation of natural killer cell homeostasis and response against viral infection by microRNA-155.
|
Proc Natl Acad Sci U S A
|
2013
|
1.12
|
75
|
The effects of commensal microbiota on immune cell subsets and inflammatory responses.
|
Immunol Rev
|
2012
|
1.11
|
76
|
Molecular aspects of regulatory T cell development.
|
Semin Immunol
|
2004
|
1.09
|
77
|
The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning.
|
J Immunol
|
2002
|
1.04
|
78
|
Roles for cathepsins S, L, and B in insulitis and diabetes in the NOD mouse.
|
J Autoimmun
|
2009
|
0.94
|
79
|
Treg cells in cancer: a case of multiple personality disorder.
|
Sci Transl Med
|
2012
|
0.93
|
80
|
Effect of decreasing the affinity of the class II-associated invariant chain peptide on the MHC class II peptide repertoire in the presence or absence of H-2M.
|
J Immunol
|
2004
|
0.86
|
81
|
Microbial metabolites control gut inflammatory responses.
|
Proc Natl Acad Sci U S A
|
2014
|
0.85
|
82
|
G protein-coupled receptor 83 is dispensable for the development and function of regulatory T cells.
|
Mol Cell Biol
|
2007
|
0.85
|
83
|
Antigen-specific dose-dependent system for the study of an inheritable and reversible phenotype in mouse CD4+ T cells.
|
Immunology
|
2002
|
0.83
|
84
|
Positive selection of self-MHC-reactive T cells by individual peptide-MHC class II complexes.
|
Proc Natl Acad Sci U S A
|
2002
|
0.81
|
85
|
Dual TCR T cells: gaining entry into the periphery.
|
Nat Immunol
|
2002
|
0.79
|
86
|
Editorial overview: lymphocyte development.
|
Curr Opin Immunol
|
2009
|
0.78
|
87
|
Pillars Article: Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells. Nat. Immunol. 2003. 4: 330-336.
|
J Immunol
|
2017
|
0.76
|
88
|
Corrigendum: Stability and function of regulatory T cells expressing the transcription factor T-bet.
|
Nature
|
2017
|
0.75
|